Severe acute respiratory syndrome (SARS) was defined as an invasive respiratory disease in 2002, which originally came from China and rapidly spread all over the globe. Acute pneumonia and lower respiratory tract involvement most affected the middle aged individuals and elderly with a mortality rate of 11%. While SARS Corona virus (SARS-CoV) has maintained its potential capacity to reemerge, clinical study of the immune system of SARS patients, as well as controlled studies may lead to application of new treatment strategies in future. Throughout this work, I have focused on early immune responses to SARS-CoV in humans and in ferrets. CXCL0 has been associated with alterations in the clinical course of several infectious diseases, includin...
AbstractImmune responses during infection with pandemic H1N1 2009 influenza A virus (2009-H1N1) are ...
The COVID-19 pandemic is entering a new era with the approval of many SARS-CoV-2 vaccines. In spite ...
There is a vital need for authentic COVID-19 animal models to enable the pre-clinical evaluation of ...
Severe acute respiratory syndrome (SARS) was defined as an invasive respiratory disease in 2002, whi...
In terms of its highly pathogenic nature, there remains a significant need to further define the imm...
<div><p>In terms of its highly pathogenic nature, there remains a significant need to further define...
Type I interferons (IFNs) are essential to the clearance of viral diseases, however, a clear distinc...
Improving COVID-19 intervention strategies partly relies on animal models to study SARS-CoV-2 diseas...
AbstractPhase I human clinical studies involving therapeutics for emerging and biodefense pathogens ...
Nonpharmaceutical interventions (NPIs) to contain the SARS-CoV-2 pandemic drastically reduced human-...
The burden of infection with seasonal influenza viruses is significant. Each year is typically chara...
The burden of infection with seasonal influenza viruses is significant. Each year is typically chara...
As the recent outbreak of SARS-CoV-2 has highlighted, the threat of a pandemic event from zoonotic v...
AbstractPhase I human clinical studies involving therapeutics for emerging and biodefense pathogens ...
While the seroprevalence of SARS-CoV-2 in healthy people does not differ significantly among age gro...
AbstractImmune responses during infection with pandemic H1N1 2009 influenza A virus (2009-H1N1) are ...
The COVID-19 pandemic is entering a new era with the approval of many SARS-CoV-2 vaccines. In spite ...
There is a vital need for authentic COVID-19 animal models to enable the pre-clinical evaluation of ...
Severe acute respiratory syndrome (SARS) was defined as an invasive respiratory disease in 2002, whi...
In terms of its highly pathogenic nature, there remains a significant need to further define the imm...
<div><p>In terms of its highly pathogenic nature, there remains a significant need to further define...
Type I interferons (IFNs) are essential to the clearance of viral diseases, however, a clear distinc...
Improving COVID-19 intervention strategies partly relies on animal models to study SARS-CoV-2 diseas...
AbstractPhase I human clinical studies involving therapeutics for emerging and biodefense pathogens ...
Nonpharmaceutical interventions (NPIs) to contain the SARS-CoV-2 pandemic drastically reduced human-...
The burden of infection with seasonal influenza viruses is significant. Each year is typically chara...
The burden of infection with seasonal influenza viruses is significant. Each year is typically chara...
As the recent outbreak of SARS-CoV-2 has highlighted, the threat of a pandemic event from zoonotic v...
AbstractPhase I human clinical studies involving therapeutics for emerging and biodefense pathogens ...
While the seroprevalence of SARS-CoV-2 in healthy people does not differ significantly among age gro...
AbstractImmune responses during infection with pandemic H1N1 2009 influenza A virus (2009-H1N1) are ...
The COVID-19 pandemic is entering a new era with the approval of many SARS-CoV-2 vaccines. In spite ...
There is a vital need for authentic COVID-19 animal models to enable the pre-clinical evaluation of ...